ICR-CTSU

@ICR_CTSU

Clinical Trials and Statistics Unit . We lead the design, conduct and analysis of national and international cancer clinical trials.

Vrijeme pridruživanja: rujan 2015.

Tweetovi

Blokirali ste korisnika/cu @ICR_CTSU

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @ICR_CTSU

  1. prije 16 sati

    Thank you to our colleagues who held a cake sale and wrote pledges to raise money for and to mark

    Poništi
  2. proslijedio/la je Tweet
    4. velj

    A great delight to spend helping junior investigators develop their cancer trials. Exciting ideas! Ended the day with an unplanned “speed trial-designing” session with several trainees. It is such a privilege to be a statistical methodologist.😊

    Poništi
  3. 4. velj

    Thank you to all participants and colleagues who contribute to our clinical trials.

    Prikaži ovu nit
    Poništi
  4. 4. velj

    We work with colleagues across the UK and internationally to design, conduct and analyse with the aim to change clinical practice. Find out more about the work we do here:

    Prikaži ovu nit
    Poništi
  5. 4. velj

    This our director Judith Bliss and Ops director are presenting on our cancer research and how supports cancer research and nationwide.

    Poništi
  6. 3. velj

    Interested in working with us as a trial administrator? We are currently recruiting:

    Poništi
  7. 29. sij

    Prof Bliss was in Madrid last night, delivering a keynote speech on the design of non-inferiority trials.

    Poništi
  8. proslijedio/la je Tweet
    27. sij
    Poništi
  9. 28. sij

    Holly, one of our PhD students is presenting her work today

    Prikaži ovu nit
    Poništi
  10. 27. sij

    This week we're at . Our Director, Prof Judith Bliss, went to the patient advocate session yesterday - great to kick off the conference by discussing their key research priorities.

    Prikaži ovu nit
    Poništi
  11. 24. sij

    Our thanks to all of the participants and colleagues across the UK who contributed to this research

    Prikaži ovu nit
    Poništi
  12. 24. sij

    The radiotherapy results were published in the Red Journal

    Prikaži ovu nit
    Poništi
  13. 24. sij

    The results of the chemotherapy part of the trial were published in the

    Prikaži ovu nit
    Poništi
  14. 24. sij

    We found that adding chemotherapy to radiotherapy for treatment of did not detrimentally impact participants’ quality of life –

    Prikaži ovu nit
    Poništi
  15. 24. sij

    We’re pleased that the patient reported quality of life study conducted as part of our BC2001 trial has now been published. and

    Prikaži ovu nit
    Poništi
  16. proslijedio/la je Tweet
    22. sij
    Poništi
  17. 15. sij

    Last week, was on discussing the new study from and using to detect breast cancer from mammograms. She looks forward to the normalisation of images across platforms, and validation of the method in .

    Poništi
  18. 7. sij

    Find out more about the 111 trial on our web page: , or read the results of the trial here: .

    Prikaži ovu nit
    Poništi
  19. 23. pro 2019.

    Merry Christmas and Happy New Year to all our trial participants, collaborators and followers! Thank you for your continued support this year.

    Poništi
  20. 23. pro 2019.

    Following the presentations at San Antonio, we have had a lot of press interest for . Thank you to all of those involved. Find out more about the trial here:

    Prikaži ovu nit
    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·